Gastroenterology Billing Services
Gastroenterology billing centers around complex endoscopic procedure coding, the critical distinction between screening and diagnostic colonoscopies, and multi-procedure bundling rules for same-session interventions. Biologic infusion therapy billing adds another layer of complexity with buy-and-bill drug management. Our GI billing specialists maximize reimbursement for every procedure while maintaining strict coding compliance.
Who This Page Is For
Common Billing Friction in Gastroenterology
Screening vs Diagnostic Colonoscopy Conversion
When a screening colonoscopy converts to a diagnostic procedure due to polyp removal or biopsy, the billing must reflect the conversion with correct modifiers (PT, 33) to prevent patient cost-sharing issues and ensure proper payer processing.
Endoscopy Multi-Procedure Bundling
Multiple endoscopic interventions performed during the same session (biopsy, polypectomy, dilation, stenting) have complex bundling rules where only the highest-value procedure may be separately billable without proper modifier usage.
Pathology and Specimen Coding Coordination
GI practices must coordinate procedure coding with pathology specimen handling, ensuring the number of specimens billed matches the number collected and documented during the endoscopic procedure.
Gastroenterology-Specific Payer Issues We Watch For
Medicare
Issue: Requires modifier PT on screening colonoscopies that convert to diagnostic to waive patient cost-sharing under the preventive benefit — incorrect modifier use shifts costs to the patient
Our approach: We apply modifier PT to every screening-to-diagnostic conversion and verify the claim processes under the preventive benefit to protect patient cost-sharing rights
UnitedHealthcare
Issue: Bundles EGD biopsy (43239) with EGD diagnostic (43235) when performed in the same session, denying the biopsy as inclusive of the base procedure
Our approach: We document distinct clinical indications for each endoscopic intervention and apply modifier 59/XS when biopsies are taken from different anatomic sites than the diagnostic examination
Aetna
Issue: Requires specific prior authorization for biologic infusions with documentation of failed step therapy (conventional medications tried and failed before biologic approval)
Our approach: We compile step therapy failure documentation including drug names, dosages, duration of use, and clinical response before submitting biologic prior authorization requests
Cigna
Issue: Applies a separate polyp surveillance guideline that differs from national recommendations, denying follow-up colonoscopies scheduled earlier than their proprietary interval
Our approach: We reference Cigna's specific surveillance interval guidelines when scheduling follow-up procedures and document clinical justification when shorter intervals are medically necessary
What We Handle
Endoscopy Procedure Billing
Complete coding of EGD, colonoscopy, and ERCP procedures with correct intervention add-on codes and modifier application.
Biologic Infusion Billing
Buy-and-bill management for Remicade, Entyvio, and other GI biologic infusions with J-code and administration coding.
Screening-to-Diagnostic Conversion
Proper modifier application when screening procedures convert to diagnostic, protecting patient cost-sharing rights.
Specimen and Pathology Coordination
Ensuring procedure codes align with specimen counts and pathology billing for biopsies and tissue samples.
ASC vs Hospital Billing
Correct facility and professional fee coding based on whether procedures are performed in an ASC or hospital setting.
Key Gastroenterology CPT Codes
| CPT Code | Description | Avg. Reimbursement |
|---|---|---|
| 45378 | Diagnostic colonoscopy | $380 |
| 45385 | Colonoscopy with polypectomy by snare | $625 |
| 45380 | Colonoscopy with biopsy | $465 |
| 43239 | EGD with biopsy | $340 |
| 43249 | EGD with balloon dilation | $520 |
| 43260 | ERCP with diagnostic evaluation | $890 |
| 91065 | Hydrogen breath test | $85 |
| J1745 | Infliximab (Remicade) injection, 10 mg | $115/unit |
Real Results
The Challenge
A 4-provider GI practice performing 300+ colonoscopies per month was losing revenue on screening-to-diagnostic conversions, multi-procedure endoscopy unbundling, and had $22K monthly in biologic infusion billing errors
Our Approach
We implemented automated screening-to-diagnostic conversion coding with PT modifier tracking, corrected endoscopy bundling using CCI-compliant modifier application, and restructured biologic buy-and-bill workflows
Key Outcomes
- check_circle Colonoscopy revenue per procedure increased by $165
- check_circle Endoscopy multi-procedure revenue increased 22%
- check_circle Biologic infusion billing errors eliminated — recovered $48K in 90 days
- check_circle Patient complaints about unexpected colonoscopy charges dropped to zero
“We were creating patient billing problems on every converted screening colonoscopy. MedPrecision fixed the modifier issue and our patients stopped getting surprised with bills.”
Why General Billing Teams Miss Gastroenterology Issues
General billing staff handle dozens of specialties and rarely develop the depth needed for gastroenterology coding nuances. Here is what gets missed.
Modifier and bundling errors
Specialty-specific modifier rules and CCI edits are frequently overlooked by teams that do not work exclusively in gastroenterology.
Under-coding high-complexity visits
Gastroenterology encounters often qualify for higher-level E/M codes, but generalist billers default to mid-level codes to avoid audit risk.
Missed payer-specific rules
Each payer has unique coverage and documentation requirements for gastroenterology procedures that general teams rarely memorize.
Slow denial turnaround
Without specialty knowledge, appeal letters lack the clinical specificity needed to overturn gastroenterology denials quickly.
“The screening-to-diagnostic colonoscopy conversion is where most GI practices create both revenue and compliance problems. One wrong modifier choice costs you the procedure payment and creates a patient billing dispute.”
MedPrecision Billing Team
GI Procedure Coding Specialist
Transition Plan
Switching billing partners should not disrupt patient care or cash flow. Our transition plan is designed for zero downtime.
Discovery and Specialty Audit
We review your current gastroenterology billing workflows, denial patterns, and payer mix to build a tailored onboarding plan.
System Integration
We connect to your EHR and practice management system, configure specialty-specific code sets, and validate charge capture workflows.
Parallel Billing Period
We run billing in parallel with your current process for 2-4 weeks to verify accuracy before taking over completely.
Full Transition and Reporting
Once validated, we assume full billing responsibility with monthly reporting dashboards and a dedicated account manager.
Gastroenterology Billing Terms
- Screening-to-Diagnostic Conversion
- When a colonoscopy initiated as a preventive screening procedure converts to a diagnostic procedure due to findings such as polyps or lesions. Requires modifier PT to preserve the patient's preventive benefit and waive cost-sharing.
- CCI Bundling Edits
- Correct Coding Initiative edits that define which GI procedure codes cannot be billed together. Endoscopy bundling rules are among the most complex in medical billing, particularly for same-session interventions.
- Buy-and-Bill
- A billing model where the practice purchases biologic medications (Remicade, Entyvio), administers them to patients, and bills the payer for both the drug cost (J-code) and the infusion administration. Requires careful drug waste documentation and inventory management.
- Modifier PT
- Colorectal cancer screening test converted to diagnostic — a modifier applied to colonoscopy claims when a screening procedure results in polyp removal or biopsy. Ensures the patient retains their preventive benefit cost-sharing protections.
- Endoscopy Base Code
- The primary procedure code for an endoscopic examination (45378 for colonoscopy, 43235 for EGD) to which intervention add-on codes are appended. Only the highest-value intervention is typically billable separately from the base code without modifiers.
- Drug Waste Documentation
- Required documentation of unused biologic medication from single-use vials. Medicare and most commercial payers reimburse for documented drug waste using modifier JW, which can represent significant revenue for infusion practices.
Last updated: 2025-03-05
Common Questions
Common questions about gastroenterology billing services.
Request a Specialty Billing Review
See how specialty-specific billing support can improve reimbursement visibility for gastroenterology billing services.
Request Review arrow_forwardHow do you handle billing when a screening colonoscopy finds and removes polyps?
We code the procedure as a colonoscopy with polypectomy using the appropriate technique-specific code (snare, hot biopsy, etc.) and apply modifier PT to indicate it began as a screening procedure. This preserves the patient's preventive screening benefit while capturing the interventional component.
Can you bill for multiple endoscopic procedures in the same session?
Yes, when properly documented and coded. We apply modifier 59 or XS to distinguish separate procedures and follow CCI bundling edits to ensure each intervention is billable. For example, a colonoscopy with both polypectomy and biopsy at different sites can be billed separately.
How do you manage biologic infusion billing for GI practices?
We handle the complete buy-and-bill cycle including drug J-code billing (J1745 for Remicade, J3380 for Entyvio), infusion administration codes with time-based add-ons, drug waste documentation, and prior authorization for continued therapy.
Related Services
Related Specialties
Related Resources
Available In
Request a Specialty Billing Review
Find out if your endoscopy and colonoscopy coding is missing revenue on modifier and pathology add-ons.